As of June 2026 Kymera Therapeutics has a market cap of A$13.79 Billion. This makes Kymera Therapeutics the world's 2093th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jun 29th, 2026 the market cap of Kymera Therapeutics was reported to be: